TMS 2026: OB/GYN visits had nearly 4-fold higher odds of menopause coding than family medicine visits, with disparities by race and insurance, a study found.
Commentary|Videos|June 5, 2025
Women’s Health Takeaways for Primary Care: Expert Insights From ACOG 2025
Fact checked by: Grace Halsey
Hear experts' takeaways from ACOG 2025 on menopause care, postpartum depression screening, and obesity management.
Advertisement
Advertisement
At the American College of Obstetricians and Gynecologists’ 2025 Annual Meeting in Minneapolis, Patient Care Online sat down with expert faculty to capture the most important clinical messages for primary care physicians. In this short video, you’ll hear final take-home points from three leaders in women’s health on managing menopause symptoms, screening for postpartum depression, and initiating evidence-based obesity treatment. These closing thoughts offer practical guidance to help you support women through every life stage.
Related to this article
TMS 2026: Women exercising at least 5 days a week reported lower perimenopause symptom scores across psychological, somatic, and urogenital domains.
TMS 2026: Menopause hormone therapy was associated with greater weight loss on semaglutide, but not sustained additional benefits with tirzepatide, in a new study.
Hormone Therapy Linked to More Frequent Migraines, but Not Greater Severity, in Postmenopausal Women
TMS 2026: A meta-analysis of 5 studies found hormone therapy linked to more frequent migraine attacks and migraine days, but not greater severity or analgesic use.
TMS 2026: In ARIC, menopause before age 40 was linked to higher CVD and CHD risk, with insulin resistance mediating about 19% of the association.
TMS 2026: Post hoc OASIS 1 and 2 data show more women on elinzanetant reported improvement across all 8 PROMIS sleep disturbance items vs placebo at week 12.
In a pilot study of 20 midlife women with vasomotor symptoms, an AI-enabled VR program delivering CBT showed early feasibility and acceptability.
Capsule-sponge DNA methylation test boosts Barrett’s screening access, showing high accuracy, strong tolerability, and promise for primary care triage to endoscopy.
Advertisement
Advertisement